US Stock MarketDetailed Quotes

MLTX MoonLake Immunotherapeutics

Watchlist
  • 41.970
  • -0.660-1.55%
Close May 9 16:00 ET
  • 41.970
  • 0.0000.00%
Post 16:01 ET
2.64BMarket Cap-58291P/E (TTM)

MoonLake Immunotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

MoonLake Immunotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--

Unlock Free Earnings Estimates

MoonLake Immunotherapeutics Earnings Reports

  • MoonLake Immunotherapeutics | 10-Q: Quarterly report

    May 7 20:04

  • MoonLake Immunotherapeutics | 10-K/A: Annual report (Amendment)

    May 7 19:59

  • MoonLake Immunotherapeutics | 10-K: Annual report

    Feb 29 21:08

  • MoonLake Immunotherapeutics: Q3 2023 Earnings Report

    Nov 14, 2023 21:05

    • Read more

    Analysis

    Analyst Rating

    Updated: May 8, 2024

    Strong Buy

    • Buy

      78.57%

    • Hold

      21.43%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg